| Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up B Escudier, C Porta, M Schmidinger, N Rioux-Leclercq, A Bex, V Khoo, ... Annals of Oncology 30 (5), 706-720, 2019 | 1567 | 2019 |
| Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience JJ Patard, E Leray, N Rioux-Leclercq, L Cindolo, V Ficarra, A Zisman, ... Journal of Clinical Oncology 23 (12), 2763-2771, 2005 | 945 | 2005 |
| Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery K Bensalah, AJ Pantuck, N Rioux-Leclercq, R Thuret, F Montorsi, ... European urology 57 (3), 466-473, 2010 | 332 | 2010 |
| Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma JJ Patard, E Leray, A Rodriguez, N Rioux-Leclercq, F Guillé, B Lobel European urology 44 (2), 226-232, 2003 | 272 | 2003 |
| Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting B Beuselinck, S Job, E Becht, A Karadimou, V Verkarre, G Couchy, ... Clinical cancer research 21 (6), 1329-1339, 2015 | 267 | 2015 |
| Prognostic significance of the mode of detection in renal tumours JJ Patard, A Rodriguez, N Rioux‐Leclercq, F Guille, B Lobel BJU international 90 (4), 358-363, 2002 | 242 | 2002 |
| Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma JJ Patard, P Fergelot, PI Karakiewicz, T Klatte, QD Trinh, ... International journal of cancer 123 (2), 395-400, 2008 | 227 | 2008 |
| Renal tumors: diagnostic and prognostic biomarkers PH Tan, L Cheng, N Rioux-Leclercq, MJ Merino, G Netto, VE Reuter, ... The American journal of surgical pathology 37 (10), 1518-1531, 2013 | 210 | 2013 |
| Prognostic value of thrombocytosis in renal cell carcinoma K Bensalah, E Leray, P Fergelot, N Rioux-Leclercq, J Tostain, F Guillé, ... The Journal of urology 175 (3), 859-863, 2006 | 209 | 2006 |
| MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array L Albiges, J Guegan, A Le Formal, V Verkarre, N Rioux-Leclercq, ... Clinical Cancer Research 20 (13), 3411-3421, 2014 | 175 | 2014 |
| Prognostic ability of simplified nuclear grading of renal cell carcinoma N Rioux‐Leclercq, PI Karakiewicz, QD Trinh, V Ficarra, L Cindolo, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 172 | 2007 |
| Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma N Rioux-Leclercq, B Turlin, JY Bansard, JJ Patard, A Manunta, ... Urology 55 (4), 501-505, 2000 | 170 | 2000 |
| Immunotherapy in renal cell carcinoma: the future is now A Deleuze, J Saout, F Dugay, B Peyronnet, R Mathieu, G Verhoest, ... International Journal of Molecular Sciences 21 (7), 2532, 2020 | 163 | 2020 |
| Understanding the importance of smart drugs in renal cell carcinoma JJ Patard, N Rioux-Leclercq, P Fergelot European urology 49 (4), 633-643, 2006 | 155 | 2006 |
| Collecting duct renal cell carcinoma: a matched analysis of 41 cases PI Karakiewicz, QD Trinh, N Rioux-Leclercq, A de la Taille, G Novara, ... European urology 52 (4), 1140-1146, 2007 | 146 | 2007 |
| Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma M Rink, BD Robinson, DA Green, EK Cha, J Hansen, E Comploj, ... The Journal of urology 188 (2), 398-404, 2012 | 141 | 2012 |
| Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading J Dagher, B Delahunt, N Rioux‐Leclercq, L Egevad, JR Srigley, ... Histopathology 71 (6), 918-925, 2017 | 139 | 2017 |
| Genome‐wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target M Gerlinger, CR Santos, B Spencer‐Dene, P Martinez, D Endesfelder, ... The Journal of pathology 227 (2), 146-156, 2012 | 138 | 2012 |
| MAGE‐A4, a germ cell specific marker, is expressed differentially in testicular tumors F Aubry, AP Satie, N Rioux‐Leclercq, E Rajpert‐De Meyts, GC Spagnoli, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2001 | 138 | 2001 |
| Identification of genital tract markers in the human seminal plasma using an integrative genomics approach AD Rolland, R Lavigne, C Dauly, P Calvel, C Kervarrec, T Freour, ... Human reproduction 28 (1), 199-209, 2013 | 126 | 2013 |
